RespiraConNosotros:a Mobile Application for COVID-19 Respiratory Rehabilitation.

January 8, 2021 updated by: Beatriz-María Bermejo-Gil, University of Salamanca

RespiraConNosotros: Creation and Implementation of a Mobile Application for the Rehabilitation of Patients With Respiratory Sequelae of the SARS-CoV-2 (COVID-19)

Platform with a mobile application to encourage the performance of respiratory exercises, controlled and supervised by physiotherapists. It also includes recommendations, frequently asked questions and the possibility of contacting by chat or video calls with experts to solve possible doubts.

Currently, the application is ready for use, the registration of users and professionals is enabled and have 20 exercises divided into three intensity levels.

It is available for all platforms (PC, ANDROID, iOS). presents a simple deployment, accessible to the entire population and does not require installation.

In the future, investigators will include more languages, a greater variety of exercises and even other types of therapies. Investigators will also carry out the adaptation to functional diversity with subtitles and voice commands.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Salamanca, Spain, 37007
        • Ines Llamas-Ramos

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Respiratory affectation diagnosis
  • Internet access to run the application

Exclusion Criteria:

  • Presence of contraindications to physical exercise or the lack of comprehensive ability to access the application will be considered.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Single group
Implementation of a mobile application for the rehabilitation of patients with respiratory sequelae of COVID-19
Other: Breathing exercise
Participants will carry out a breathing exercise program through the RespiraConNosotros mobile application. They will be asked to carry out the proposed exercises with a frequency of 3 times a week for 3 months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rating of perceived exertion (Borg Scale)
Time Frame: 10 minutes.
Scale from 1-10 points. Where number 1 means very light activity and 10, represents an extreme intensity of activity.
10 minutes.
Level of satisfaction and acceptability.
Time Frame: 20 minutes.
A Likert-type scale will be used. 1-Not Satisfied to 5-Extremely satisfied.
20 minutes.
St. George's Respiratory Questionnaire, SGRQ
Time Frame: 40 minutes.
scale from 0-100 points.Where higher scores mean worse outcomes.
40 minutes.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age
Time Frame: 2 minutes.
The date of birth will be registered in order to calculate the age of the participant.
2 minutes.
Sex
Time Frame: 2 minutes.
Participant's sex will be registered
2 minutes.
Diagnosis of respiratory pathology
Time Frame: 2 minutes.
Participant's diagnosis will be registered.
2 minutes.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Salamanca

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 20, 2021

Primary Completion (Anticipated)

April 20, 2021

Study Completion (Anticipated)

April 20, 2021

Study Registration Dates

First Submitted

January 4, 2021

First Submitted That Met QC Criteria

January 8, 2021

First Posted (Actual)

January 11, 2021

Study Record Updates

Last Update Posted (Actual)

January 12, 2021

Last Update Submitted That Met QC Criteria

January 8, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CovidSal02

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Covid19

Clinical Trials on Breathing exercise

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe